Carl Figdor and Michiel Vermeulen participate in Oncode Institute

https://www.radboudumc.nl/en/news/2018/carl-figdor-and-michiel-vermeulen-participate-in-oncode-institute

https://portal.umcn.nl/nieuws/Lists/Nieuws/DispForm.aspx?ID=5853&Source=https%3A%2F%2Fportal%2Eumcn%2Enl%2Fnieuws%2FPages%2Fhome%2Easpx

 

Carl Figdor and Michiel Vermeulen participate in the Oncode Institute for Radboudumc and Radboud University, respectively.

Research programme

Despite enormous progress in our understanding of cancer, the chance of long-term survival remains small for many patients, particularly those with metastatic disease. Oncode will address this unmet clinical need through an innovative basic research programme. True innovation in the treatment of cancer relies on new insights into the basic mechanisms of oncogenesis, which in turn depend heavily on technological innovation. Oncode research will be guided by a number of key questions that need to be resolved to extend life expectancy and improve quality of life for cancer patients.